Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Leprosy Review is Scopus-indexed (Q3, CiteScore 1.3), WoS SCIE, DOAJ. Published by Lepra.
Checked against the index lists dated .
ISSN 0305-7518Verify ISSN ↗2162-8807Verify ISSN ↗
Publisher: Lepra
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Dermatology | 100 / 152 | 34th | Q3 |
| Infectious Diseases | 269 / 361 | 25th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1950–present (also 1945–1948), best quartile Q3, CiteScore 1.3.
Leprosy Review is Q3 in Dermatology (rank 100 of 152) and Q3 in Infectious Diseases (rank 269 of 361), by CiteScore 2025.
Leprosy Review is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q3 at the 34th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.295, quartile Q3, with an H-index of 53.
Leprosy Review is published by Lepra. Its print ISSN is 0305-7518 and its online ISSN is 2162-8807.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Leprosy Review has an h-index of 66 and a 2-year mean of 0.53 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #103 of 144 Scopus journals in Dermatology.
Leprosy Review published 61 papers in 2025; its busiest recent year was 2017 with 64. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 90 research articles (2024–2026), authors are most often from India (38.2%), Indonesia (10.3%) and Brazil (10.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.